Relationship between Time Initial Administration of Norepinephrine and 24-hour Mortality in Septic Shock at Emergency Department Chiangrai Prachanukroh Hospital, Thailand

Authors

  • Phruetthiphong Pawarachan Emergency Department, Chiangrai Prachanukroh Hospital, Chiang Rai Province, Thailand
  • Yuttana Kowjiriyapan Emergency Department, Chiangrai Prachanukroh Hospital, Chiang Rai Province, Thailand
  • Kriangsak Pintatham Emergency Department, Chiangrai Prachanukroh Hospital, Chiang Rai Province, Thailand

DOI:

https://doi.org/10.14456/jemst.2022.5

Keywords:

mortality, septic shock, norepinephrine

Abstract

Septic shock is an important global healthcare problem with a high mortality rate, causing unsatisfied outcome. The recent survival sepsis campaign bundle 2018 update recommended to apply vasopressors within the first hour to achieve mean arterial pressure ≥65 mm Hg for improved outcome. This study aimed to evaluate the relationship between time of initial administration of vasopressor and 24-hour mortality in septic shock patients. It was conducted as a retrospective cohort study using data from 262 adult septic shock patients treated at Emergency Department of Chiangrai Prachanukhroh Hospital during January 2016 – January 2021. The primary outcome was the relationship between time initial Norepinephrine and death in 24-hour. It was found that among 262 patients, 114 were administered norepinephrine within 60 minutes, average time to initiate Norepinephrine was 42±15.87) minutes competed to the average time to initiate norepinephrine in the late group which was 93±37.73 minutes (p<0.001). This study found there was no statistically significant in mortality in 24-hour in septic shock patients [crude RR=0.89, (95%CI=0.43-1.85, p=0.759)]. In conclusion, time to initiate norepinephrine within 60 minutes in septic shock patients at emergency department of Chiangrai Prachanukroh Hospital was not associated with 24-hour mortality.

References

Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DD. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. The Lancet 2020Jan; 395(10219): 200–11.

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. New England Journal of Medicine 2001; 345(19): 1368–77. 3. Cinel I, Kasapoglu US, Gul F, Dellinger RP. The initial resuscitation of septic shock. Journal of Critical Care 2020; 57: 108–17.

Kelm DJ, Perrin JT, Cartin-Ceba R, Gajic O, Schenck L, Kennedy CC. Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock 2015; 43(1): 68–73.

Hamzaoui O, Shi R. Early norepinephrine use in septic shock. J Thorac Dis 2020; 12(S1):73–7.

กลุ่มงานอายุรกรรม. แนวทางการดูแลผู้ป่ วย Sepsis Version 2 [อินเทอร์เน็ต]. โรงพยาบาลเชียงรายประชานุเคราะห์. 2565 [สืบค้นเมื่อ 9 มิ.ย. 2565]. แหล่งข้อมูล: http://49.231.15.21/deptw13/upload/files/her cF256312 041721022781.pdf

Hamzaoui O, Scheeren TWL, Teboul J-L. Norepinephrine in septic shock. Curr Opin Crit Care 2017;23(4): 342–7.

Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign. Crit Care Med 2013; 41(2):580–637.

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017;43(3): 304–77.

Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle. Crit Care Med 2018;46(6):997– 1000.

Scheeren TW, Bakker J, De Backer D, Annane D, Asfar P, Boerma EC, et al. Current use of vasopressors in septic shock. Annals of Intensive Care 2019; 9(1):1–12.

Bai X, Yu W, Ji W, Lin Z, Tan S, Duan K, et al. Early versus delayed administration of norepinephrine in patients with septic shock. Critical Care 2014;18(5).

Elbouhy MA, Soliman M, Gaber A, Taema KM, Abdel-Aziz A. Early use of norepinephrine improves survival in septic shock: Earlier than early. Arch Med Res 2019;50(6):325–32.

Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med 2019;199(9): 1097–105.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016; 315(8):801.

Hidalgo DC, Patel J, Masic D, Park D, Rech MA. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care 2020;55: 145–8.

Li Y, Li H, Zhang D. Timing of norepinephrine initiation in patients with septic shock: A systematic review and meta-analysis. Critical Care 2020;24(1):1-9.

Ospina-Tascón GA, Hernandez G, Alvarez I, CalderónTapia LE, Manzano-Nunez R, Sánchez-Ortiz AI, et al. Effects of very early start of norepinephrine in patients with septic shock: A propensity score-based analysis. Critical Care 2020; 24(1):1–11.

Marik PE, Linde-Zwirble WT, Bittner EA, Sahatjian J, Hansell D. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med 2017;43(5):625- 32.

Downloads

Published

2022-07-19

How to Cite

1.
Pawarachan P, Kowjiriyapan Y, Pintatham K. Relationship between Time Initial Administration of Norepinephrine and 24-hour Mortality in Septic Shock at Emergency Department Chiangrai Prachanukroh Hospital, Thailand. Jemst-01JHS [internet]. 2022 Jul. 19 [cited 2025 Mar. 14];2(1):47-5. available from: https://he03.tci-thaijo.org/index.php/Jemst-01JHS/article/view/313

Issue

Section

Original Article